Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Par...

FDA Recall #D-0874-2022 — Class II — April 22, 2022

Recall #D-0874-2022 Date: April 22, 2022 Classification: Class II Status: Terminated

Product Description

Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

Reason for Recall

CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recalling Firm

Pfizer Inc. — New York, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

8346 bottles

Distribution

Nationwide and Puerto Rico

Code Information

Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls